{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:15:59Z","timestamp":1789143359963,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117190","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T16:24:55Z","timestamp":1785083095000},"page":"117190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PLOD2 promotes colorectal cancer progression and immune escape via attenuating CD8+ T cells function"],"prefix":"10.1016","volume":"187","author":[{"given":"Zhangquan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117190_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42237","article-title":"A novel gene signature for predicting outcome in colorectal cancer patients based on tumor cell-endothelial cell interaction via single-cell sequencing and machine learning","volume":"11","author":"Pang","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.117190_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1399569","article-title":"Effect of body mass index on survival in patients with metastatic colorectal cancer receiving chemotherapy plus bevacizumab: a systematic review and meta-analysis","volume":"11","author":"Lang","year":"2024","journal-title":"Front. Nutr."},{"issue":"8","key":"10.1016\/j.intimp.2026.117190_bb0015","doi-asserted-by":"crossref","DOI":"10.4240\/wjgs.v17.i8.107785","article-title":"Surgical treatment of colorectal cancer: a multidimensional review","volume":"17","author":"Mao","year":"2025","journal-title":"World J Gastrointest Surg."},{"key":"10.1016\/j.intimp.2026.117190_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2024.1398289","article-title":"Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC","volume":"11","author":"Zheng","year":"2024","journal-title":"Front. Surg."},{"issue":"4","key":"10.1016\/j.intimp.2026.117190_bb0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2026.117190_bb0030","article-title":"Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF\/c-MET signaling","volume":"14","author":"Albadari","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117190_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103866","article-title":"Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model","volume":"76","author":"Cai","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.intimp.2026.117190_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.46094","article-title":"Liver metastases and immune checkpoint inhibitor efficacy in patients with refractory metastatic colorectal Cancer: a secondary analysis of a randomized clinical trial","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jjco\/hyaa200","article-title":"Current status and perspectives of immune checkpoint inhibitors for colorectal cancer","volume":"51","author":"Hirano","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117190_bb0050","first-page":"894","article-title":"Application of immune checkpoint inhibitors in colorectal cancer","volume":"46","author":"Wang","year":"2021","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.intimp.2026.117190_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2021.07.023","article-title":"Current status and future perspective of immune checkpoint inhibitors in colorectal cancer","volume":"521","author":"Zhou","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12967-024-05426-x","article-title":"Comprehensive investigation of malignant epithelial cell-related genes in clear cell renal cell carcinoma: development of a prognostic signature and exploration of tumor microenvironment interactions","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7150\/jca.35763","article-title":"Overexpressing PLOD family genes predict poor prognosis in gastric cancer","volume":"11","author":"Li","year":"2020","journal-title":"J. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2026.117190_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.553","article-title":"PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC","volume":"8","author":"Du","year":"2017","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.intimp.2026.117190_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121842","article-title":"Identification and validation of PLOD2 as an adverse prognostic biomarker for oral squamous cell carcinoma","volume":"11","author":"Sun","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/mmr.2024.13388","article-title":"PLOD2 exacerbates cervical squamous cell carcinoma by suppressing p53 by binding to YAP1","volume":"31","author":"Yin","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.117190_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071764","article-title":"Hypoxia, hypoxia-inducible factors and liver fibrosis","volume":"10","author":"Foglia","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.intimp.2026.117190_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1139\/bcb-2019-0256","article-title":"PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2","volume":"98","author":"Du","year":"2020","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117190_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1427348","article-title":"Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/23523735251322017","article-title":"Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: current status and future perspectives","volume":"11","author":"Yoshihara","year":"2025","journal-title":"Bladder Cancer."},{"key":"10.1016\/j.intimp.2026.117190_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/bmri\/1532745","article-title":"Applications and prospects of single-cell RNA sequencing and spatial transcriptomics in cervical cancer","author":"Wang","year":"2025","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.intimp.2026.117190_bb0110","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/cas.15851","article-title":"PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT\/mTOR signaling pathway","volume":"114","author":"Lan","year":"2023","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.117190_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116037","article-title":"PLOD2 is a prognostic marker in glioblastoma that modulates the immune microenvironment and tumor progression","volume":"23","author":"Kre\u00dfe","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.intimp.2026.117190_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174345","article-title":"Immune-checkpoint inhibitors for metastatic colorectal Cancer: a systematic review of clinical outcomes","volume":"13","author":"Shek","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.intimp.2026.117190_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf255","article-title":"First-line PD-1 +\/\u2212 CTLA-4 blockade in patients with deficient mismatch repair and\/or microsatellite instability-high metastatic colorectal cancer","volume":"30","author":"Nasca","year":"2025","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.intimp.2026.117190_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008210","article-title":"Multiomic molecular characterization of the response to combination immunotherapy in MSS\/pMMR metastatic colorectal cancer","volume":"12","author":"Takei","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"36","key":"10.1016\/j.intimp.2026.117190_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202508040","article-title":"Personalized neoantigen vaccine plus regorafenib increases Rgs2+CD8+ T cells infiltration and reprograms the tumor microenvironment in microsatellite stable colorectal cancer liver metastases","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.117190_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307128","article-title":"The efficacy of Pembrolizumab, Ipilimumab, and Nivolumab monotherapy and combination for colorectal cancer: a systematic review and meta-analysis","volume":"20","author":"Adrianto","year":"2025","journal-title":"PloS One"},{"issue":"6282","key":"10.1016\/j.intimp.2026.117190_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2026.117190_bb0150","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","article-title":"Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc","volume":"6","author":"Wang","year":"2024","journal-title":"Nat. Metab."},{"issue":"12","key":"10.1016\/j.intimp.2026.117190_bb0155","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.immuni.2024.10.014","article-title":"Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling","volume":"57","author":"Ogishi","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56498-2","article-title":"Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites","volume":"16","author":"Teng","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","article-title":"C-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"2","key":"10.1016\/j.intimp.2026.117190_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41419-024-06469-0","article-title":"FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0180","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1038\/s41467-022-31238-y","article-title":"Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.intimp.2026.117190_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213732","article-title":"Proteomes of residual tumors in curcumin-treated rats reveal changes in microenvironment\/malignant cell crosstalk in a highly invasive model of mesothelioma","volume":"23","author":"Pouliquen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2026.117190_bb0190","doi-asserted-by":"crossref","DOI":"10.31083\/FBL46316","article-title":"Cancer-associated fibroblast-centric risk model predicts immunotherapy resistance in pancreatic cancer and reveals PLOD2 as a key stromal therapeutic target","volume":"30","author":"Cao","year":"2025","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.intimp.2026.117190_bb0195","article-title":"Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.intimp.2026.117190_bb0200","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/cancers15153898","article-title":"Metabolites and immune response in tumor microenvironments","volume":"15","author":"Cortellino","year":"2023","journal-title":"Cancers (Basel)."},{"issue":"10","key":"10.1016\/j.intimp.2026.117190_bb0205","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.3390\/ijms24108707","article-title":"The tango between Cancer-associated fibroblasts (CAFs) and immune cells in affecting immunotherapy efficacy in pancreatic Cancer","volume":"24","author":"Stouten","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117190_bb0210","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04226-0","article-title":"Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types","volume":"79","author":"Willumsen","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.117190_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104204","article-title":"Improving the efficiency of immune checkpoint inhibitors for metastatic pMMR\/MSS colorectal cancer: options and strategies","volume":"200","author":"Yang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"38","key":"10.1016\/j.intimp.2026.117190_bb0220","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1038\/s41388-023-02806-3","article-title":"ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer","volume":"42","author":"Zhang","year":"2023","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.intimp.2026.117190_bb0225","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1080\/15548627.2025.2551680","article-title":"KDM4A-induced tumor senescence enhances the efficacy of immunotherapy by inhibiting AGT-PHB1 axis-mediated mitophagy in colorectal cancer","volume":"21","author":"Cai","year":"2025","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0230","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41420-023-01472-4","article-title":"SIRP\u03b1 blockade improves the antitumor immunity of radiotherapy in colorectal cancer","volume":"9","author":"Ji","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117190_bb0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12935-017-0420-z","article-title":"Hypoxia and TGF-\u03b21 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation","volume":"17","author":"Xu","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.117190_bb0240","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2017.04.023","article-title":"PLOD2 in cancer research","volume":"90","author":"Du","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2026.117190_bb0245","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/2159-8290.CD-13-0118","article-title":"Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis","volume":"3","author":"Eisinger-Mathason","year":"2013","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.intimp.2026.117190_bb0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1541-7786.MCR-15-0307","article-title":"Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma","volume":"14","author":"Pankova","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"20","key":"10.1016\/j.intimp.2026.117190_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214942120","article-title":"The PLOD2\/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness","volume":"120","author":"Tong","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.intimp.2026.117190_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003484","article-title":"ZEB1 transcription factor promotes immune escape in melanoma","volume":"10","author":"Plaschka","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117190_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","article-title":"Transcriptional regulation of EMT transcription factors in cancer","volume":"97","author":"Saitoh","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.117190_bb0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2024.06.001","article-title":"RNA regulatory mechanisms controlling TGF-\u03b2 signaling and EMT in cancer","volume":"102-103","author":"Bracken","year":"2024","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117190_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114453","article-title":"Knockdown of PLOD2 inhibits pulmonary artery smooth muscle cell glycolysis under chronic intermittent hypoxia via PI3K\/AKT signal","volume":"446","author":"Yi","year":"2025","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.117190_bb0280","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41419-023-06298-7","article-title":"Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117190_bb0285","article-title":"Targeting PLOD2 induces epithelioid differentiation and improves therapeutic response in sarcomatoid renal cell carcinoma","author":"Chen","year":"2025","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117190_bb0290","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.matbio.2005.04.002","article-title":"Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: implications for collagen cross-linking and treatment of fibrosis","volume":"24","author":"Zuurmond","year":"2005","journal-title":"Matrix Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:50Z","timestamp":1789142510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"alternative-id":["S1567576926010362"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117190","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLOD2 promotes colorectal cancer progression and immune escape via attenuating CD8+ T cells function","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117190"}}